|
Activity of tmRNA -1 triplet mutants in the KanR assay |
|||
| UUU X |
UCU X |
UAU X |
UGU X |
| UUC 10 |
UCC 100 |
UAC 25 |
UGC 100 |
| UUA X |
UCA 35 |
UAA X |
UGA X |
| UUG X |
UCG 100 |
UAG 100 |
UGG 50 |
|
|
|||
| CUU X |
CCU X |
CAU 40 |
CGU X |
| CUC 50 |
CCC 50 |
CAC 100 |
CGC 60 |
| CUA X |
CCA 100 |
CAA X |
CGA X |
| CUG 100 |
CCG 100 |
CAG 90 |
CGG 20 |
|
|
|||
| AUU 90 |
ACU X |
AAU 90 |
AGU 100 |
| AUC 100 |
ACC 100 |
AAC 80 |
AGC 100 |
| AUA 60 |
ACA 100 |
AAA 100 |
AGA 100 |
| AUG 100 |
ACG 100 |
AAG 100 |
AGG 100 |
|
|
|||
| GUU 90 |
GCU X |
GAU 100 |
GGU 100 |
| GUC 100 |
GCC 100 |
GAC 100 |
GGC 100 |
| GUA X |
GCA X |
GAA 95 |
GGA 100 |
| GUG 100 |
GCG 25 |
GAG 100 |
GGG 100 |
|
tmRNA directs the addition of the last 15 amino acids of KanR onto ribosomes stalled on a kanR template in Escherichia coli. Only cells with functional tmRNA survive on 30 μg/ml kanamycin [11]. Each -1 triplet mutant was tested individually and the data reported as percentage survival on selective (kanamycin) media. Triplets listed as X showed no survival. Triplets forbidden by the rules developed by Lim and Garber [16] are underlined and in bold type. | |||
Miller et al. BMC Biology 2008 6:29 doi:10.1186/1741-7007-6-29 |
|||